Background
While biologics offer promise in addressing a range of unmet medical needs, clinically observed BILI events are concerning for drug developers, health care providers and patients. QST modeling, combined with in vitro data, can improve understanding of BILI mechanisms and help predict hepatotoxicity in humans.
By James Beaudoin, Lara Clemens, Lawrence A. Vernetti, Mark T. Miedel, Michael W. Castiglione, D. Lansing Taylor#, Francisco Huizar, Celeste Vallejo, Conner I. Sandefur, Michael Kelley, Vinal V. Lakhani, Christina Battista, Scott Q. Siler, Lisl K.M. Shoda, Brett A. Howell, Kyunghee Yang
ASCPT 2025 Annual Meeting, May 28- 31, 2025, Washington, D.C.